Cristina Larrosa

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 8

Top Topics

Hodgkin Lymphoma

Radiation Induced

Stem Cell Transplantation

Top Venues

Pediatric blood & cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Maite Gorostegui, Juan Pablo Muñoz, Sara Perez-Jaume, Margarida Simao-Rafael, Cristina Larrosa, Moira Garraus, Noelia Salvador, Cinzia Lavarino, Lucas Krauel, Salvador Mañe, Alicia Castañeda, Jaume Mora
Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy. Cancers 16 (9) (2024)
Cristina Larrosa, Soraya Mico, Mónica Ramos, Sara Perez-Jaume, Mónica Sánchez, Alicia Castañeda, Moira Garraus, Jaume Catala-Mora
Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes. Pediatric blood & cancer (2024)
Maite Gorostegui, Juan Pablo Muñoz, Sara Perez-Jaume, Margarida Simao-Rafael, Cristina Larrosa, Moira Garraus, Noelia Salvador, Cinzia Lavarino, Lucas Krauel, Salvador Mañe, Alicia Castañeda, Jaume Mora
Management of High-Risk Neuroblastoma with Soft-Tissue-Only Disease in the Era of Anti-GD2 Immunotherapy. Cancers 16 (9) (2024)
Cristina Larrosa, Soraya Mico, Mónica Ramos, Sara Perez-Jaume, Mónica Sánchez, Alicia Castañeda, Moira Garraus, Jaume Catala-Mora
Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes. Pediatric blood & cancer 71 (10) (2024)
Juan Pablo Muñoz, Cristina Larrosa, Saray Chamorro, Sara Perez-Jaume, Margarida Simao, Nazaret Sanchez-Sierra, Amalia Varo, Maite Gorostegui, Alicia Castañeda, Moira Garraus, Sandra Lopez-Miralles, Jaume Mora
Early Salvage Chemo-Immunotherapy with Irinotecan, Temozolomide and Naxitamab Plus GM-CSF (HITS) for Patients with Primary Refractory High-Risk Neuroblastoma Provide the Best Chance for Long-Term Outcomes. Cancers 15 (19) (2023)
Cristina Larrosa, Jaume Mora, Nai Kong V Cheung
Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2. Cancers 15 (14) (2023)
Jaume Mora, Alicia Castañeda, Maite Gorostegui, Amalia Varo, Sara Perez-Jaume, Margarida Simao, Juan Pablo Muñoz Pérez, Moira Garraus, Cristina Larrosa, Noelia Salvador, Cinzia Lavarino, Lucas Krauel, Salvador Mañe
Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use-Updated Outcome Report. Cancers 15 (9) (2023)
Jaume Mora, Alicia Castañeda, Maite Gorostegui, Amalia Varo, Sara Perez-Jaume, Margarida Simao, Juan Pablo Muñoz Pérez, Moira Garraus, Cristina Larrosa, Noelia Salvador, Cinzia Lavarino, Lucas Krauel, Salvador Mañe
Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use-Updated Outcome Report. Cancers 15 (9) (2023)